3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
56
Neoplasms
20
Pain
18
Fatigue
11
Peripheral Nervous System Diseases
10
Lung Neoplasms
10
Hot Flashes
10
Prostatic Neoplasms
9
Multiple Myeloma
9
Polycystic Ovary Syndrome
7
Sleep Initiation and Maintenance Disorders
6
Anxiety Disorders
6
Stomach Neoplasms
5
Pancreatic Neoplasms
5
Depression
5
Colorectal Neoplasms
5
Agnosia
5
Lymphoma
4
Lymphedema
4
Insulin Resistance
4
Head and Neck Neoplasms
4
Cancer Pain
4
Xerostomia
3
Squamous Cell Carcinoma of Head and Neck
3
Nasopharyngeal Neoplasms
3
Lymphoma, Non-Hodgkin
3
Gastrointestinal Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Vomiting
2
Interventions
Metformin
8
Progesterone
6
Spironolactone
4
drospirenone and ethinyl estradiol combination
3
Inositol
3
Ethinyl Estradiol
3
salicylsalicylic acid
2
Sugars
2
Folic Acid
2
Flutamide
2
Estradiol
2
Cyproterone Acetate
2
Clomiphene
2
maltodextrin
1
licogliflozin
1
bicalutamide
1
Yoga
1
Topiramate
1
Thioctic Acid
1
Sodium Salicylate
1
Phlebotomy
1
Ovidrel
1
Magnesium
1
Lactalbumin
1
Inulin
1
Glycoprotein Hormones, alpha Subunit
1
Estrogens
1
Doxycycline
1
Dexamethasone
1
Cyproterone acetate, ethinyl estradiol drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Hyperandrogenism
×
Acupuncture Therapy
×
Clear all
NCT02647827
2024-10-09
PIAII
Karolinska Institutet
Phase 2
Recruiting
303 enrolled